Cargando…
Reimbursement and use of intensity-modulated radiation therapy for prostate cancer
The use of intensity-modulated radiation therapy (IMRT) for prostate cancer increased through the mid-2000s, in association with acquisition of the devices by large urology groups. More recently, reimbursement for IMRT in the office setting (generally representing freestanding facilities owned by ph...
Autores principales: | Shahinian, Vahakn B., Kaufman, Samuel R., Yan, Phyllis, Herrel, Lindsey A., Borza, Tudor, Hollenbeck, Brent K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484181/ https://www.ncbi.nlm.nih.gov/pubmed/28640073 http://dx.doi.org/10.1097/MD.0000000000006929 |
Ejemplares similares
-
Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2015) -
Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022) -
The primary treatment of prostate cancer with high-intensity focused ultrasound: A systematic review and meta-analysis
por: He, Yue, et al.
Publicado: (2020) -
Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis
por: Yuan, Jin-Qiu, et al.
Publicado: (2015) -
The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
por: Choi, Se Young, et al.
Publicado: (2021)